Having established that primary CD4+ T cells increase their glycolytic rate in response to infection with HIV-1, we sought to manipulate the metabolism of the cell to determine whether the glycolytic metabolism impacts on the fate of the infected cell and the viral replication cycle. This evidence concerns the gene CD4 and infection.